CLINICAL_TRIALS
trial_result
· 2014-08-22
Clinical Trial Update: Phase II Study of Bevacizumab (Avastin®) in Myelofibrosis [Phase 2]
Summary
A Phase II trial of bevacizumab in myelofibrosis was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ronald Hoffman | Conditions: Myelofibrosis | Phase 2 | Status: TERMINATED | Results posted: 2014-08-22